In Depth 7 May 2025 Unlocking immunity: the power of TLR agonists Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial. May 7, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 7 May 2025 Top biotech deals of April 2025 Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery. May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 6 May 2025 The future of diabetes treatment: Is a cure possible? Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we? May 6, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 May 2025 The biggest biotech funding rounds in April 2025 The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April 2025 May 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Webinars 5 May 2025AI in antibody discovery: From in silico analysis to AI-enabled data management Explore how AI and bioinformatics are reshaping antibody discovery, from in silico design to efficient data management. May 5, 2025 Share WhatsApp Twitter Linkedin Email
In Depth 2 May 2025 From pandemic spotlight to post-COVID crossroads: What happened to these biotech players? Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article. May 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 2 May 2025TCR-NK: A novel cell therapy transforming cancer treatment Are TCR-NK treatments the next big thing in cell therapies for cancer patients? Find out in our talk with Namir Hassan, CEO of Zelluna. May 2, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 30 Apr 2025 The future of NSCLC treatment: what’s in store for the therapeutic space? Here we delve into the different kinds of NSCLC therapies in the running to potentially address late-stage cancer that is often difficult to treat. April 30, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Apr 2025 Six biotech companies leading the charge in hemophilia treatment Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies. April 29, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2025 U.S. budget cuts: what is the impact on therapeutic research? We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits. April 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Whitepapers 28 Apr 2025Function-focused single-cell analysis to accelerate antibody discovery Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies. April 28, 2025 Share WhatsApp Twitter Linkedin Email
In Depth 25 Apr 2025 The past, present, and future of genome sequencing Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome, a step-by-step decoding of all the genetic instructions. In humans, that means reading around 3 billion base pairs to reveal everything from disease risk and drug response to ancestry and evolution. For many years, genome sequencing was largely limited to […] April 25, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email